Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

ClinicalTrials.gov ID: NCT02542215

Public ClinicalTrials.gov record NCT02542215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects With Head and Neck Cancer (HNC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Treatment for head and neck cancer often involves a combination of chemotherapy and radiation. One of the unfortunate consequences of standard care for head and neck cancer is the development of painful mouth sores, known as oral mucositis. This study will evaluate the use of cobiprostone spray to prevent oral mucositis, when given for the duration of radiation and chemotherapy (RT/CT) standard care.

Study identification

NCT ID
NCT02542215
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sucampo Pharma Americas, LLC
Industry
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Jun 30, 2016
Completion
Jun 30, 2016
Last update posted
Dec 1, 2019

2015 – 2016

United States locations

U.S. sites
76
U.S. states
35
U.S. cities
75
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35294
Investigational Site Peoria Arizona 85381
Investigational Site Yuma Arizona 85364
Investigational Site Little Rock Arkansas 72205
Investigational Site Duarte California 91010
Investigational Site Fullerton California 92835
Investigational Site Los Angeles California 90048
Investigational Site Montebello California 90640
Investigational Site Oceanside California 92056
Investigational Site Redondo Beach California 90277
Investigational Site San Francisco California 94115
Investigational Site Whittier California 90603
Investigational Site Denver Colorado 80210
Investigational Site Farmington Connecticut 06030
Investigational Site Fort Lauderdale Florida 33316
Investigational Site Fort Myers Florida 33908
Investigational Site Lakeland Florida 33805
Investigational Site Miami Beach Florida 33140
Investigational Site Naples Florida 34102
Investigational Site Plantation Florida 33322
Investigational Site Stuart Florida 34994
Investigational Site Winter Haven Florida 33880
Investigational Site Boise Idaho 83706
Investigational Site Urbana Illinois 61801
Investigational Site Fort Wayne Indiana 46845
Investigational Site South Bend Indiana 46601
Investigational Site Topeka Kansas 66606
Investigational Site Ashland Kentucky 41101
Investigational Site Baton Rouge Louisiana 70809
Investigational Site Metairie Louisiana 70006
Investigational Site New Orleans Louisiana 70112
Investigational Site Shreveport Louisiana 71103
Investigational Site Baltimore Maryland 21201
Investigational Site Bethesda Maryland 20889
Investigational Site Burlington Massachusetts 01805
Investigational Site Ann Arbor Michigan 48109
Investigational Site Detroit Michigan 48201
Investigational Site East Lansing Michigan 48867
Investigational Site Minneapolis Minnesota 55417
Investigational Site St Louis Missouri 63110
Investigational Site Billings Montana 59101
Investigational Site Omaha Nebraska 68198
Investigational Site Reno Nevada 89502
Investigational Site Egg Harbor New Jersey 08234
Investigational Site New Brunswick New Jersey 08901
Investigational Site Charlotte North Carolina 28203
Investigational Site Gastonia North Carolina 28054
Investigational Site Greenville North Carolina 27834
Investigational Site Canton Ohio 44718
Investigational Site Sylvania Ohio 43560
Investigational Site Oklahoma City Oklahoma 73104
Investigational Site Coos Bay Oregon 97420
Investigational Site Corvallis Oregon 97330
Investigational Site Portland Oregon 97227
Investigational Site Gettysburg Pennsylvania 17325
Investigational Site Hershey Pennsylvania 17033
Investigational Site Natrona Heights Pennsylvania 15065
Investigational Site Philadelphia Pennsylvania 19104
Investigational Site Pittsburgh Pennsylvania 15232
Investigational Site State College Pennsylvania 16801
Investigational Site Pawtucket Rhode Island 02860
Investigational Site Myrtle Beach South Carolina 29577
Investigational Site Cookeville Tennessee 38501
Investigational Site Austin Texas 78701
Investigational Site Fort Sam Houston Texas 78234
Investigational Site Galveston Texas 77555
Investigational Site Houston Texas 77030
Investigational Site Houston Texas 77089
Investigational Site Temple Texas 76508
Investigational Site Charlottesville Virginia 22911
Investigational Site Fort Belvoir Virginia 22060
Investigational Site Bellingham Washington 98225
Investigational Site Everett Washington 98201
Investigational Site Seattle Washington 98101
Investigational Site Morgantown West Virginia 26506
Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Oral Mucositis trials

Other public records listing Oral Mucositis. Sorted by last update posted; newest first. Not a recommendation.

All Oral Mucositis trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02542215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2019 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02542215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →